Literature DB >> 12746835

A novel method of generating prostate cancer metastases from orthotopic implants.

Eva Corey1, Janna E Quinn, Robert L Vessella.   

Abstract

BACKGROUND: Spontaneous metastasis following implantation at the orthotopic site is a highly desired feature in prostate cancer (CaP) models, since it would enable studies of mechanisms associated with tumor cell dissemination.
METHODS: LuCaP 23.8 and LuCaP 35, hormone-sensitive CaP xenografts that express PSA and the wild-type androgen receptor, were grown orthotopically in SCID mice. When tumor volumes reached approximately 250-500 mg, primary tumors were removed to allow micrometastases to grow.
RESULTS: Using this procedure we generated macroscopic metastases (>20 mg) in 71% (LuCaP 23.8) and 100% (LuCaP 35) of animals, respectively.
CONCLUSIONS: These models may be used to evaluate new treatment modalities and study mechanisms associated with development of metastases. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746835     DOI: 10.1002/pros.10235

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  12 in total

1.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.

Authors:  Akash Kumar; Thomas A White; Alexandra P MacKenzie; Nigel Clegg; Choli Lee; Ruth F Dumpit; Ilsa Coleman; Sarah B Ng; Stephen J Salipante; Mark J Rieder; Deborah A Nickerson; Eva Corey; Paul H Lange; Colm Morrissey; Robert L Vessella; Peter S Nelson; Jay Shendure
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 3.  Human prostate cancer heterotransplants: a review on this experimental model.

Authors:  Lluis A Lopez-Barcons
Journal:  Asian J Androl       Date:  2010-04-05       Impact factor: 3.285

Review 4.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

Review 5.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

6.  An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2.

Authors:  C Andrew Boswell; Eduardo E Mundo; Ron Firestein; Crystal Zhang; Weiguang Mao; Herman Gill; Cynthia Young; Nina Ljumanovic; Shannon Stainton; Sheila Ulufatu; Aimee Fourie; Katherine R Kozak; Reina Fuji; Paul Polakis; Leslie A Khawli; Kedan Lin
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 7.  Serially heterotransplanted human prostate tumours as an experimental model.

Authors:  Lluis-A Lopez-Barcons
Journal:  J Cell Mol Med       Date:  2009-10-29       Impact factor: 5.310

Review 8.  The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.

Authors:  Sourik S Ganguly; Xiaohong Li; Cindy K Miranti
Journal:  Front Oncol       Date:  2014-12-15       Impact factor: 6.244

9.  Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy.

Authors:  Manish Kohli; Liguo Wang; Fang Xie; Hugues Sicotte; Ping Yin; Scott M Dehm; Steven N Hart; Peter T Vedell; Poulami Barman; Rui Qin; Douglas W Mahoney; Rachel E Carlson; Jeanette E Eckel-Passow; Thomas D Atwell; Patrick W Eiken; Brendan P McMenomy; Eric D Wieben; Gautam Jha; Rafael E Jimenez; Richard Weinshilboum; Liewei Wang
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

Review 10.  Skeletal metastasis: treatments, mouse models, and the Wnt signaling.

Authors:  Kenneth C Valkenburg; Matthew R Steensma; Bart O Williams; Zhendong Zhong
Journal:  Chin J Cancer       Date:  2013-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.